Oral contraceptives: Current status

Clinical Obstetrics and Gynecology

Volumn 44, Issue 1, 2001, Pages 62-72

  Burkman, R T ^a  

^a Dept of Obstetrics and Gynecology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; ORAL CONTRACEPTIVE AGENT;

AFFECTIVE NEUROSIS; BREAST CANCER; CANCER PREVENTION; CANCER RISK; DISEASE ASSOCIATION; DOSE CALCULATION; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG INDICATION; FEMALE; HEART INFARCTION; HUMAN; MENSTRUATION DISORDER; NAUSEA; ORAL CONTRACEPTION; PATIENT EDUCATION; REVIEW; STROKE;

ACNE VULGARIS; ADULT; ARTHRITIS, RHEUMATOID; BONE DENSITY; BREAST NEOPLASMS; CEREBROVASCULAR ACCIDENT; COLORECTAL NEOPLASMS; CONTRACEPTION; CONTRACEPTIVES, ORAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LEIOMYOMA; MENSTRUATION DISTURBANCES; MYOCARDIAL INFARCTION; OVARIAN CYSTS; OVARIAN NEOPLASMS; PATIENT COMPLIANCE; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PREGNANCY, ECTOPIC; RISK FACTORS; THROMBOEMBOLISM;

EID: 0035130787     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200103000-00010     Document Type: Review

References (29)

1. Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms
2. Contraceptive failure in the United States: A critical review of the literature
3. A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and triphasic oral contraceptives on follicular development
4. Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease
5. Consensus conference on combination oral contraceptives and cardiovascular disease
6. The epidemiology of oral contraceptive use: A critical review of the studies on oral contraceptives and the health of young women
7. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
8. Blood coagulation and oral contraceptives. A critical review
9. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women
10. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies
11. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer
12. Oral contraceptive discontinuation: A prospective evaluation of frequency and reasons
13. Clinical comparison of triphasic norgestimate/35 μg ethinyl estradiol and monophasic norethindrone acetate/20 μg ethinyl estradiol. Cycle control, lipid effects, and user satisfaction
14. Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: A randomized trial of 20-μg and 35-μg estrogen preparations
15. The health effects of oral contraceptives: Misperceptions, controversies, and continuing good news
16. A quantitative assessment of oral contraceptive use and risk of ovarian cancer
17. Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women?
18. Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner's guide to meta-analysis
19. Oral contraceptive use and risk of benign breast disease in a French case-control study of young women
20. Triphasic norgestimate/ethinyl estradiol oral contraceptive for the treatment of dysfunctional uterine bleeding
21. The use of oral contraceptives by adolescents for contraception, menstrual cycle problems, or acne
22. Management of the fibroid uterus
23. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: A randomized, placebo-controlled trial
24. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris
25. Bone-sparing properties of oral contraceptives
26. Oral-contraceptive use and risk of hip fracture: A case-control study
27. Oral contraceptive use and risk of colorectal cancer
28. The protective effect of the oral contraceptive pill on rheumatoid arthritis: An overview of the analytic epidemiological studies using meta-analysis